Patient Journey in Hospital With Heart Failure in Turkish Population

Heart Failure Clinical Trial

— JournayHF-TR  

Official title:

A Multicentre, Prospective, Observational, Hospital-based Registry of Patients With Acute Heart Failure Those Whose Care Was Guided by a Cardiologist in Turkey

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02487056
• Other study ID #: JournayHF-TR
• Status: Completed
• Start date: September 2015
• Est. completion date: August 2016

Study information

• Verified date: March 2020
• Source: Ege University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to compose a national database of the etiologies, clinical and demographic characteristics, using diagnostic tests, precipitating and risk factors, management of from intensive care unit or coronary care unit to hospital discharge, length of stay in the intensive care unit and hospital, in-hospital mortality and discharge medications of hospitalized acute heart failure patients in Turkish population.

Description:

The etiologies, precipitating factors, demographics, clinical characteristics, management and outcome of patients admitted in hospital with acute heart failure in Turkish population will be recorded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1622
• Est. completion date: August 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients >18 years olds

• Clinical diagnosis of acute heart failure

• Admitted to the participating hospitals

Exclusion Criteria:

• Patients <18 years old

• Patients with acute heart failure who are discharged from the emergency room without admission.

• Failure to obtain informed consent

Related Conditions & MeSH terms

• Heart Failure

Locations

Country	Name	City	State
Turkey	Ahmet Ekmekçi	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Ege University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence to European Heart Failure Guideline	To assess number of patients managed and treated following the last European Heart Failure Guidelines	Admission to Hospital (Enrollment)
Secondary	Length of Hospitalisation	Length of stay in hospital in Turkish population admitted to study	In-Hospital
Secondary	Mortality	All cause death	1 month